📋1. OVERVIEW & PROTOCOL

• Compound Structure: TB-500 is a 43-amino-acid synthetic analogue of Thymosin Beta-4 (Tβ4) that has been extensively investigated for its interactions with actin-regulatory systems.
• Biological Focus: In vitro studies document interactions involved in cytoskeletal organization, actin-dependent signaling, and intracellular structural dynamics.
• Cellular Intensity: Experimental investigations examine its ability to influence actin polymerization dynamics, structural protein networks, and pathway-specific regulatory processes.

🧪2. CHEMICAL PROPERTIES

• Chemical Formula: C212H350N56O78S
• Molar Mass: 4693 g/mol
• CAS Number: 77591-33-4
• PubChem CID: 16132341
• Shelf Life & Stability: 36 months under controlled, cool, and dry storage conditions.
• Available Variations: 2mg 1 Vial | 2mg 10 Vials | 5mg 1 Vial | 5mg 10 Vials | 10mg 1 Vial | 10mg 10 Vials

🔬3. AUDITED RESEARCH & SPECIFICATIONS

• Stability Advantage: Lyophilized powder format meticulously developed as a stable reference compound to withstand enzymatic breakdown during clinical testing.
• Signaling Pathways: Highly focused on structural protein architecture, actin-binding mechanisms, and cellular migration networks during tissue repair modeling.
• TB-500 Comparison: Frequently studied alongside distinct research agents due to its unique actin sequestration capabilities and specific cellular motility profiling.